rdf:type |
|
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0011306,
umls-concept:C0024518,
umls-concept:C0034790,
umls-concept:C0035668,
umls-concept:C0039194,
umls-concept:C0205245,
umls-concept:C0205263,
umls-concept:C0441655,
umls-concept:C0679058,
umls-concept:C1282910,
umls-concept:C1510996,
umls-concept:C1515895,
umls-concept:C1547699,
umls-concept:C1947910,
umls-concept:C2700640
|
pubmed:issue |
10
|
pubmed:dateCreated |
2009-9-4
|
pubmed:abstractText |
Adoptive transfer of T cells expressing transgenic T-cell receptors (TCRs) with antitumor function is a hopeful new therapy for patients with advanced tumors; however, there is a critical bottleneck in identifying high-affinity TCR specificities needed to treat different malignancies. We have developed a strategy using autologous dendritic cells cotransfected with RNA encoding an allogeneic major histocompatibility complex molecule and a tumor-associated antigen to obtain allo-restricted peptide-specific T cells having superior capacity to recognize tumor cells and higher functional avidity. This approach provides maximum flexibility because any major histocompatibility complex molecule and any tumor-associated antigen can be combined in the dendritic cells used for priming of autologous T cells. TCRs of allo-restricted T cells, when expressed as transgenes in activated peripheral blood lymphocytes, transferred superior function compared with self-restricted TCR. This approach allows high-avidity T cells and TCR specific for tumor-associated self-peptides to be easily obtained for direct adoptive T-cell therapy or for isolation of therapeutic transgenic TCR sequences.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1528-0020
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2131-9
|
pubmed:meshHeading |
pubmed-meshheading:19587379-Adoptive Transfer,
pubmed-meshheading:19587379-Antigens, Neoplasm,
pubmed-meshheading:19587379-Cell Line, Tumor,
pubmed-meshheading:19587379-Dendritic Cells,
pubmed-meshheading:19587379-HLA Antigens,
pubmed-meshheading:19587379-Humans,
pubmed-meshheading:19587379-Isoantigens,
pubmed-meshheading:19587379-Neoplasms,
pubmed-meshheading:19587379-Peptides,
pubmed-meshheading:19587379-RNA,
pubmed-meshheading:19587379-Receptors, Antigen, T-Cell,
pubmed-meshheading:19587379-T-Lymphocytes,
pubmed-meshheading:19587379-Transfection
|
pubmed:year |
2009
|
pubmed:articleTitle |
Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity.
|
pubmed:affiliation |
Institute of Molecular Immunology, Helmholtz Zentrum München, German Research Center for Environmental Health, Marchioninistrasse 25, Munich, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|